DNTH · Dianthus Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Third Rock Ventures IV, L.P. 10% Owner | ▼ Sell | Open Market | 3,058,204 Shares held | 2/8/2023 | View profile |
| Meng Lei | ▲ Buy | Grant | 2,717,554 Shares held | 1/22/2024 | View profile |
| Leon O. Moulder Jr. Chief Executive Officer | ▲ Buy | Grant | 1,436,745 Shares held | 1/22/2024 | View profile |
| GARDNER JASON See Remarks | ▲ Buy | Grant | 292,872 Shares held | 11/30/2022 | View profile |
| Marino Garcia CEO AND PRESIDENT | ▼ Sell | Open Market | 65,292 Shares held | 8/7/2026 | View profile |
| Stants Kristen Chief People Officer | ▲ Buy | Grant | 20,264 Shares held | 11/30/2022 | View profile |
| Beetham Thomas W. Chief Operating Officer | ▲ Buy | Grant | 19,897 Shares held | 11/30/2022 | View profile |
| Deardorf Caren Chief Commercial Officer | ▲ Buy | Grant | 19,762 Shares held | 11/30/2022 | View profile |
| Mahoney Stephen F. President and CEO | ▲ Buy | Grant | 17,264 Shares held | 11/30/2022 | View profile |
| Adam M. Veness SVP, General Counsel and Sec. | ▲ Buy | Option Exercise | 15,000 Shares held | 8/13/2026 | View profile |
| Nichols David Wayne Chief Technical Officer | ▼ Sell | Open Market | 14,306 Shares held | 9/16/2021 | View profile |
| Olson Lisa See Remarks | ▼ Sell | Open Market | 14,264 Shares held | 9/16/2021 | View profile |
| Alexis Borisy Director | ▼ Sell | Other | 4,100 Shares held | 8/26/2021 | View profile |
| Simrat Randhawa EVP, Head of R&D | ▼ Sell | Open Market | 4,000 Shares held | 9/1/2026 | View profile |
| Fairmount Funds Management LLC Director | ▼ Sell | Other | 0 Shares held | 9/27/2024 | View profile |
| Anne McGeorge | ▼ Sell | Open Market | 0 Shares held | 8/10/2026 | View profile |
| Simon Read | ▼ Sell | Open Market | 0 Shares held | 8/19/2026 | View profile |
| Ryan Savitz CFO & CBO | ▼ Sell | Open Market | 0 Shares held | 7/9/2026 | View profile |
| Paula Soteropoulos Director | ▼ Sell | Open Market | 0 Shares held | 5/8/2026 | View profile |
| Edward Carr CHIEF ACCOUNTING OFFICER | ▼ Sell | Open Market | 0 Shares held | 9/17/2026 | View profile |
Transaction History
| Edward Carr | ▲ Buy | Option Exercise | 20,000 | $358K | 9/17/2026 |
| Edward Carr | ▼ Sell | Open Market | 7,928 | $796K | 9/17/2026 |
| Edward Carr | ▼ Sell | Open Market | 6,771 | $686K | 9/17/2026 |
| Edward Carr | ▼ Sell | Open Market | 3,501 | $358K | 9/17/2026 |
| Edward Carr | ▼ Sell | Open Market | 1,100 | $114K | 9/17/2026 |
| Edward Carr | ▼ Sell | Open Market | 700 | $73K | 9/17/2026 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 7,500 | $134K | 9/1/2026 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 6,249 | $136K | 9/1/2026 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 9,375 | $207K | 9/1/2026 |
| Simrat Randhawa | ▼ Sell | Open Market | 2,600 | $273K | 9/1/2026 |
| Simrat Randhawa | ▼ Sell | Open Market | 13,309 | $1.4M | 9/1/2026 |
| Simrat Randhawa | ▼ Sell | Open Market | 7,215 | $767K | 9/1/2026 |
| Simon Read | ▲ Buy | Option Exercise | 2,778 | $51K | 8/19/2026 |
| Simon Read | ▼ Sell | Open Market | 2,778 | $327K | 8/19/2026 |
| Adam M. Veness | ▲ Buy | Option Exercise | 15,000 | $273K | 8/13/2026 |
| Simon Read | ▼ Sell | Open Market | 831 | $91K | 8/10/2026 |
| Simon Read | ▼ Sell | Open Market | 272 | $30K | 8/10/2026 |
| Anne McGeorge | ▲ Buy | Option Exercise | 1,250 | $24K | 8/10/2026 |
| Anne McGeorge | ▲ Buy | Option Exercise | 6,500 | $73K | 8/10/2026 |
| Anne McGeorge | ▼ Sell | Open Market | 1,450 | $156K | 8/10/2026 |
| Anne McGeorge | ▼ Sell | Open Market | 2,800 | $303K | 8/10/2026 |
| Anne McGeorge | ▼ Sell | Open Market | 1,800 | $197K | 8/10/2026 |
| Anne McGeorge | ▼ Sell | Open Market | 1,000 | $111K | 8/10/2026 |
| Anne McGeorge | ▼ Sell | Open Market | 700 | $78K | 8/10/2026 |
| Simon Read | ▲ Buy | Option Exercise | 2,777 | $51K | 8/10/2026 |
| Simon Read | ▼ Sell | Open Market | 70 | $7K | 8/10/2026 |
| Simon Read | ▼ Sell | Open Market | 737 | $80K | 8/10/2026 |
| Simon Read | ▼ Sell | Open Market | 470 | $52K | 8/10/2026 |
| Simon Read | ▼ Sell | Open Market | 397 | $44K | 8/10/2026 |
| Adam M. Veness | ▲ Buy | Option Exercise | 16,167 | $289K | 8/10/2026 |
| Adam M. Veness | ▼ Sell | Open Market | 16,167 | $1.8M | 8/10/2026 |
| Marino Garcia | ▼ Sell | Open Market | 2,536 | $279K | 8/7/2026 |
| Marino Garcia | ▼ Sell | Open Market | 800 | $89K | 8/7/2026 |
| Marino Garcia | ▼ Sell | Open Market | 104,091 | $11.2M | 8/7/2026 |
| Marino Garcia | ▼ Sell | Open Market | 21,909 | $2.4M | 8/7/2026 |
| Adam M. Veness | ▲ Buy | Option Exercise | 3,833 | $69K | 8/7/2026 |
| Adam M. Veness | ▼ Sell | Open Market | 3,217 | $356K | 8/7/2026 |
| Adam M. Veness | ▼ Sell | Open Market | 616 | $68K | 8/7/2026 |
| Marino Garcia | ▲ Buy | Option Exercise | 40,000 | $338K | 8/7/2026 |
| Marino Garcia | ▲ Buy | Option Exercise | 126,000 | $1.1M | 8/7/2026 |
| Marino Garcia | ▼ Sell | Open Market | 10,384 | $1.1M | 8/7/2026 |
| Marino Garcia | ▼ Sell | Open Market | 23,907 | $2.6M | 8/7/2026 |
| Marino Garcia | ▼ Sell | Open Market | 2,373 | $259K | 8/7/2026 |
| Ryan Savitz | ▲ Buy | Option Exercise | 31,249 | $680K | 7/9/2026 |
| Ryan Savitz | ▼ Sell | Open Market | 10,354 | $1.0M | 7/9/2026 |
| Ryan Savitz | ▼ Sell | Open Market | 15,329 | $1.6M | 7/9/2026 |
| Ryan Savitz | ▼ Sell | Open Market | 5,566 | $568K | 7/9/2026 |
| Adam M. Veness | ▲ Buy | Option Exercise | 30,000 | $536K | 6/17/2026 |
| Adam M. Veness | ▼ Sell | Open Market | 16,771 | $1.3M | 6/17/2026 |
| Adam M. Veness | ▼ Sell | Open Market | 13,229 | $1.1M | 6/17/2026 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 3,998 | $34K | 6/1/2026 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 6,908 | $124K | 6/1/2026 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 6,249 | $136K | 6/1/2026 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 9,375 | $207K | 6/1/2026 |
| Simrat Randhawa | ▼ Sell | Open Market | 5,428 | $487K | 6/1/2026 |
| Simrat Randhawa | ▼ Sell | Open Market | 16,943 | $1.5M | 6/1/2026 |
| Simrat Randhawa | ▼ Sell | Open Market | 4,159 | $380K | 6/1/2026 |
| Paula Soteropoulos | ▲ Buy | Option Exercise | 599 | $5K | 5/8/2026 |
| Paula Soteropoulos | ▼ Sell | Open Market | 599 | $51K | 5/8/2026 |
| Ryan Savitz | ▼ Sell | Open Market | 8,224 | $739K | 4/9/2026 |
| Ryan Savitz | ▲ Buy | Option Exercise | 8,224 | $147K | 4/9/2026 |
| Ryan Savitz | ▼ Sell | Open Market | 59,800 | $5.0M | 3/31/2026 |
| Ryan Savitz | ▼ Sell | Open Market | 2,366 | $196K | 3/31/2026 |
| Ryan Savitz | ▼ Sell | Open Market | 19,469 | $1.6M | 3/31/2026 |
| Ryan Savitz | ▼ Sell | Open Market | 7,232 | $619K | 3/31/2026 |
| Paula Soteropoulos | ▼ Sell | Open Market | 599 | $48K | 3/31/2026 |
| Paula Soteropoulos | ▲ Buy | Option Exercise | 599 | $5K | 3/31/2026 |
| Ryan Savitz | ▲ Buy | Option Exercise | 74,367 | $628K | 3/31/2026 |
| Ryan Savitz | ▲ Buy | Option Exercise | 40,000 | $715K | 3/31/2026 |
| Ryan Savitz | ▼ Sell | Open Market | 1,390 | $109K | 3/31/2026 |
| Ryan Savitz | ▼ Sell | Open Market | 21,825 | $1.7M | 3/31/2026 |
| Ryan Savitz | ▼ Sell | Open Market | 1,485 | $119K | 3/31/2026 |
| Ryan Savitz | ▼ Sell | Open Market | 800 | $65K | 3/31/2026 |
| Paula Soteropoulos | ▲ Buy | Option Exercise | 27,594 | $233K | 3/24/2026 |
| Paula Soteropoulos | ▼ Sell | Open Market | 27,594 | $2.2M | 3/24/2026 |
| Marino Garcia | ▲ Buy | Option Exercise | 59,700 | $400K | 3/16/2026 |
| Marino Garcia | ▲ Buy | Option Exercise | 5,592 | $100K | 3/16/2026 |
| Edward Carr | ▲ Buy | Option Exercise | 10,000 | $218K | 3/12/2026 |
| Edward Carr | ▼ Sell | Open Market | 15,852 | $1.3M | 3/12/2026 |
| Edward Carr | ▼ Sell | Open Market | 200 | $17K | 3/12/2026 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 8,332 | $181K | 3/12/2026 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 12,500 | $276K | 3/12/2026 |
| Marino Garcia | ▲ Buy | Option Exercise | 122,918 | $824K | 3/12/2026 |
| Marino Garcia | ▼ Sell | Open Market | 43,505 | $3.5M | 3/12/2026 |
| Marino Garcia | ▼ Sell | Open Market | 65,517 | $5.4M | 3/12/2026 |
| Edward Carr | ▲ Buy | Option Exercise | 16,182 | $289K | 3/12/2026 |
| Edward Carr | ▲ Buy | Option Exercise | 17,500 | $386K | 3/12/2026 |
| Edward Carr | ▼ Sell | Open Market | 3,865 | $319K | 3/12/2026 |
| Edward Carr | ▼ Sell | Open Market | 300 | $26K | 3/12/2026 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 7,998 | $68K | 3/12/2026 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 5,000 | $89K | 3/12/2026 |
| Edward Carr | ▼ Sell | Open Market | 23,465 | $1.9M | 3/12/2026 |
| Marino Garcia | ▼ Sell | Open Market | 12,796 | $1.1M | 3/12/2026 |
| Marino Garcia | ▼ Sell | Open Market | 200 | $17K | 3/12/2026 |
| Marino Garcia | ▼ Sell | Open Market | 900 | $77K | 3/12/2026 |
| Simrat Randhawa | ▼ Sell | Open Market | 33,830 | $2.8M | 3/12/2026 |
| Ryan Savitz | ▲ Buy | Option Exercise | 20,000 | $169K | 12/4/2025 |
| Ryan Savitz | ▼ Sell | Open Market | 20,000 | $904K | 12/4/2025 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 40,287 | $720K | 11/14/2025 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 37,494 | $816K | 11/14/2025 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 31,250 | $690K | 11/14/2025 |
| Simrat Randhawa | ▼ Sell | Open Market | 109,031 | $4.2M | 11/14/2025 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 83,978 | $709K | 11/13/2025 |
| Simrat Randhawa | ▲ Buy | Option Exercise | 3,529 | $63K | 11/13/2025 |
| Simrat Randhawa | ▼ Sell | Open Market | 26,166 | $937K | 11/13/2025 |
| Simrat Randhawa | ▼ Sell | Open Market | 42,765 | $1.6M | 11/13/2025 |
| Simrat Randhawa | ▼ Sell | Open Market | 18,576 | $701K | 11/13/2025 |
| Ryan Savitz | ▲ Buy | Option Exercise | 20,000 | $169K | 9/9/2025 |
| Ryan Savitz | ▼ Sell | Open Market | 20,000 | $700K | 9/9/2025 |
| Fairmount Funds Management LLC | ▼ Sell | Other | 62,146 | $0 | 9/27/2024 |
| Fairmount Funds Management LLC | ▼ Sell | Other | 58,857 | — | 4/1/2024 |
| Fairmount Funds Management LLC | ▼ Sell | Other | 58,857 | — | 4/1/2024 |
| Fairmount Funds Management LLC | ▲ Buy | Grant | 834,334 | $10.0M | 1/22/2024 |
| Meng Lei | ▲ Buy | Grant | 1,500,000 | $18.0M | 1/22/2024 |
| Leon O. Moulder Jr. | ▲ Buy | Grant | 166,667 | $2.0M | 1/22/2024 |
| Fairmount Funds Management LLC | ▲ Buy | Open Market | 24,670 | $336K | 9/29/2023 |
| Fairmount Funds Management LLC | ▲ Buy | Open Market | 30,000 | $395K | 9/26/2023 |
| Simrat Randhawa | ▲ Buy | Open Market | 2,000 | $26K | 9/22/2023 |
| Simrat Randhawa | ▲ Buy | Open Market | 2,000 | $26K | 9/21/2023 |
| Fairmount Funds Management LLC | ▲ Buy | Open Market | 30,000 | $396K | 9/19/2023 |
| Fairmount Funds Management LLC | ▲ Buy | Open Market | 9,367 | $110K | 9/13/2023 |
| Fairmount Funds Management LLC | ▲ Buy | Open Market | 14,887 | $162K | 9/12/2023 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 1,500,000 | $1.2M | 2/8/2023 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 2,200,000 | $1.8M | 2/7/2023 |
| Mahoney Stephen F. | ▲ Buy | Grant | 3,000 | $3K | 11/30/2022 |
| Stants Kristen | ▲ Buy | Grant | 3,000 | $3K | 11/30/2022 |
| Beetham Thomas W. | ▲ Buy | Grant | 3,000 | $3K | 11/30/2022 |
| Deardorf Caren | ▲ Buy | Grant | 3,000 | $3K | 11/30/2022 |
| GARDNER JASON | ▲ Buy | Grant | 3,000 | $3K | 11/30/2022 |
| Beetham Thomas W. | ▲ Buy | Grant | 3,000 | $3K | 5/31/2022 |
| Deardorf Caren | ▲ Buy | Grant | 3,000 | $3K | 5/31/2022 |
| Stants Kristen | ▲ Buy | Grant | 3,000 | $3K | 5/31/2022 |
| GARDNER JASON | ▲ Buy | Grant | 3,000 | $3K | 5/31/2022 |
| Beetham Thomas W. | ▼ Sell | Open Market | 6,103 | $41K | 9/16/2021 |
| Olson Lisa | ▼ Sell | Open Market | 5,736 | $39K | 9/16/2021 |
| Nichols David Wayne | ▼ Sell | Open Market | 5,694 | $38K | 9/16/2021 |
| GARDNER JASON | ▼ Sell | Open Market | 14,340 | $97K | 9/16/2021 |
| Stants Kristen | ▼ Sell | Open Market | 5,736 | $39K | 9/16/2021 |
| Mahoney Stephen F. | ▼ Sell | Open Market | 5,736 | $39K | 9/16/2021 |
| Deardorf Caren | ▼ Sell | Open Market | 6,238 | $42K | 9/16/2021 |
| GARDNER JASON | ▲ Buy | Grant | 50,000 | $0 | 9/14/2021 |
| Stants Kristen | ▲ Buy | Grant | 20,000 | $0 | 9/14/2021 |
| Nichols David Wayne | ▲ Buy | Grant | 20,000 | $0 | 9/14/2021 |
| Beetham Thomas W. | ▲ Buy | Grant | 20,000 | $0 | 9/14/2021 |
| Deardorf Caren | ▲ Buy | Grant | 20,000 | $0 | 9/14/2021 |
| Olson Lisa | ▲ Buy | Grant | 20,000 | $0 | 9/14/2021 |
| Mahoney Stephen F. | ▲ Buy | Grant | 20,000 | $0 | 9/14/2021 |
| Alexis Borisy | ▼ Sell | Other | 4,100 | $0 | 8/26/2021 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Other | 1,250,000 | — | 8/25/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
DNTH Highlighted by Benzinga and Announces Nasdaq Inducement Grants
Dianthus Therapeutics was named one of the top three health‑care stocks in a recent Benzinga feature that looks at companies that could help improve a portfolio this quarter. The company also disclosed that it will issue inducement grants under Nasdaq Listing Rule 5635(c)(4), a filing that relates to compliance with Nasdaq’s listing standards. Both items raise the company’s public profile and address regulatory requirements.
DNTH Highlighted by Benzinga and Announces Nasdaq Inducement Grants. Dianthus Therapeutics was named one of the top three health‑care stocks in a recent Benzinga feature that looks at companies that could help improve a portfolio this quarter. The company also disclosed that it will issue inducement grants under Nasdaq Listing Rule 5635(c)(4), a filing that relates to compliance with Nasdaq’s listing standards. Both items raise the company’s public profile and address regulatory requirements.